Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna-Maria Georgoudaki

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Immunotherapy|July 20, 2010
Suicide gene therapy for graft-versus-host diseaseAnna-Maria Georgoudaki, Tolga Sutlu, Evren Alici
Cancers|September 28, 2021
Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic MelanomaAmanda A van Vliet, Anna-Maria Georgoudaki, Monica Raimo, et al.
Cancer Research|May 10, 2013
Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomesUlf Gehrmann, Stefanie Hiltbrunner, Anna-Maria Georgoudaki, et al.
Advances in Experimental Medicine and Biology|June 29, 2021
Sarcoma Tumor MicroenvironmentPanagiotis Tsagozis, Jordi Gonzalez-Molina, Anna-Maria Georgoudaki, et al.
Journal of Hematology & Oncology|November 9, 2022
Natural killer cells in clinical development as non-engineered, engineered, and combination therapiesNina Lamers-Kok, Denise Panella, Anna-Maria Georgoudaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2016
Cutting Edge: Marginal Zone Macrophages Regulate Antigen Transport by B Cells to the Follicle in the Spleen via CD21Kajsa E Prokopec, Anna-Maria Georgoudaki, Silke Sohn, et al.
Journal of Leukocyte Biology|April 22, 2009
Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cellsSebastian Seth, Anna-Maria Georgoudaki, Benedict J Chambers, et al.
Iscience|June 10, 2025
CD28 signaling domain boosts persistence and <i>in vivo</i> anti-tumor activity of stem cell-derived CD19-CAR-NK cellsNina Kok, Didem Ozkazanc, Amanda A van Vliet, et al.
Journal of Autoimmunity|December 26, 2012
AIRE expressing marginal zone dendritic cells balances adaptive immunity and T-follicular helper cell recruitmentEvelina Lindmark, Yunying Chen, Anna-Maria Georgoudaki, et al.
Iscience|July 10, 2023
Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34<sup>+</sup> progenitor cell-derived NK cellsAmanda A van Vliet, Ella Peters, Denise Vodegel, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Immunotherapy|July 20, 2010
Suicide gene therapy for graft-versus-host diseaseAnna-Maria Georgoudaki, Tolga Sutlu, Evren Alici
Cancers|September 28, 2021
Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic MelanomaAmanda A van Vliet, Anna-Maria Georgoudaki, Monica Raimo, et al.
Cancer Research|May 10, 2013
Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomesUlf Gehrmann, Stefanie Hiltbrunner, Anna-Maria Georgoudaki, et al.
Advances in Experimental Medicine and Biology|June 29, 2021
Sarcoma Tumor MicroenvironmentPanagiotis Tsagozis, Jordi Gonzalez-Molina, Anna-Maria Georgoudaki, et al.
Journal of Hematology & Oncology|November 9, 2022
Natural killer cells in clinical development as non-engineered, engineered, and combination therapiesNina Lamers-Kok, Denise Panella, Anna-Maria Georgoudaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2016
Cutting Edge: Marginal Zone Macrophages Regulate Antigen Transport by B Cells to the Follicle in the Spleen via CD21Kajsa E Prokopec, Anna-Maria Georgoudaki, Silke Sohn, et al.
Journal of Leukocyte Biology|April 22, 2009
Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cellsSebastian Seth, Anna-Maria Georgoudaki, Benedict J Chambers, et al.
Iscience|June 10, 2025
CD28 signaling domain boosts persistence and <i>in vivo</i> anti-tumor activity of stem cell-derived CD19-CAR-NK cellsNina Kok, Didem Ozkazanc, Amanda A van Vliet, et al.
Journal of Autoimmunity|December 26, 2012
AIRE expressing marginal zone dendritic cells balances adaptive immunity and T-follicular helper cell recruitmentEvelina Lindmark, Yunying Chen, Anna-Maria Georgoudaki, et al.
Iscience|July 10, 2023
Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34<sup>+</sup> progenitor cell-derived NK cellsAmanda A van Vliet, Ella Peters, Denise Vodegel, et al.
Pageof 3